INO Stock News: Inovio Pharmaceuticals Inc. trades flat above the $23.00 mark
|- Inovio Pharmaceuticals Inc. (NASDAQ: INO) extends the consolidation near $23.00.
- US markets are expected to open slightly on the defensive.
Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO) keep the apathetic mood at the end of the week and are currently gyrating around the $23.00 area.
While several companies still in the race to develop a coronavirus vaccine, Inovio Pharmaceuticals Inc. (NASDAQ: INO) is planning to start the Phase 2/3 of the study for its vaccine candidate this summer (pending FDA approval).
On the broader view, US benchmark stock indices are set to open slightly on the defensive on Friday, as concerns over the unabated coronavirus pandemic and its impact on the ongoing recovery seems to have started to worry investors.
INO Stock Quote
As of writing NASDAQ: INO is up 0.39% at $23.36 and faces the next support at $16.92 (monthly high May 20) seconded by $15.68 (55-day SMA) and finally $11.13 (monthly high Jun.8). On the upside, a surpass of $24.99 (weekly high Jul.7) would expose $33.79 (monthly high Jun.23) and then $40.00 (high September 2000).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.